secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iris Acquisition Corp (—)
CIK:        0001831874
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0001104659-24-033506
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iris Acquisition extends business combination deadline to June 9, 2024; increases promissory note to $2.5M
--------------------------------------------------------------------------------

- Stockholders approved charter amendment extending deadline to June 9, 2024, with Board discretion for additional 3 months.
- Promissory note with Liminatus Pharma increased from $1.5M to $2.5M; $981,500 remains available drawn in six advances.
- 119,572 shares redeemed at ~$10.65 each, leaving ~$3.08M in trust and 7,187,037 shares outstanding.
- Entered administrative support agreement with Arrow Capital for $10,000/month starting Jan 1, 2024 until liquidation or deal closing.
- Stockholder votes were unanimous (7,045,922 For, 0 Against) for extension and adjournment proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831874/000110465924033506/0001104659-24-033506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831874/000110465924033506/tm248555d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-033506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer